Navigation Links
Maximo VR Model 7232

ProductsMaximo VR Model 7232
Company Medtronic Inc.
Item Maximo VR Model 7232
Features 
Description The Medtronic InSync Maximo, Model 7303, incorporates new advances in CRT and ICD therapy. High Output Built on the Proven Marquis ICD Platform. With this device, we offer:
  • 35 Joule, high energy output in 9 seconds or less throughout the life of the device
  • 6 years of longevity* (14% increase in longevity over InSync II Marquis)
  • Separately programmable ventricular outputs for adapting pacing outputs to unique patient needs
  • Atrial monitoring functions that help physicians manage heart failure patients who also experience atrial fibrillation.
  • Painless antitachycardia pacing (ATP) therapy to terminate three-out-of-four episodes of fast ventricular tachycardia (VT)47
  • Enhanced PR Logic dual-chamber detection achieving 95.2% accuracy (positive predictive value - PPV) in delivered therapies48
  • The Medtronic exclusive Heart Failure Management Report showing 14-month trends of key heart failure patient monitoring categories such as AT/AF Burden, ventricular rate during AF, heart rate variability, patient activity and night/day heart rates.
  • Exclusive Observation messages highlighting heart failure related parameters outside of typical ranges
  • The Medtronic exclusive Cardiac Compass Report with additional information about ventricular arrhythmia detection and therapies
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Reliance Stool, Model 5346
2. Reliance Stools, Model 5340
3. Reliance Stool, Model 5356
4. Reliance Stool, Model 5348
5. Pachymetric Analyzer Model 55
6. Model 1990 Dermatome
7. The New Model C Dermatome
8. NEW Padgett Model PI - Electro-Dermatome
9. Amo Phaco Model Diplomax
10. KR 4.22 Programmable Refrigerated Floor Model Centrifuge.
11. Model 420 UV Visible Spectrophotometer
Iridectomy
...d Super Macula® 2.2 offers extremely high reso...vea, while achieving an exceptionally wide 78°...or critical evaluation of the optic nerve head and...f the macula and disc. Redesigned to reduce weight...
...Equator is designed for focal laser therapy and mi...ptical design presents a realistic contour of the ...ld view of the entire posterior pole extending to ...ws dynamic movement on the globe, therefore increa...
...0x Imaging Lens is optimized for the visible spect...ns during general diagnosis and slit lamp imaging....posterior pole and a sharper image across the diam...s also ideal for slit lamp photography. For best r...
Medicine Products:
(Date:11/28/2009)...recognize signs of depression , , SATURD...the holiday season can trigger melancholy as they ...issues or worry about money problems, according to...rcome the seasonal blues, the AGS Foundation for H...t out and socialize or invite family and friends o...
(Date:11/27/2009)...wire-FirstCall/ -- The Gymboree Corporation (Nasda...will present at the NASDAQ OMX 23rd Investor Progr...ndon, England, on Wednesday, December 2, 2009, at ...t of The Gymboree Corporation,s presentation over ...lick on "Our Company" at the bottom of the page, g...
(Date:11/27/2009)...icles may reduce future disease burden, researcher...s) -- Encouraging city dwellers to walk and bicycl...ublic health benefits than increased used of low-e..., The study compared the projected health effects ...ios for London, England, and Delhi, India: busine...
(Date:11/27/2009)...facturers who use medical load cells at the heart ...y bringing in technology partner Flintec early in ...ve medical manufacturers are calling in Flintec lo...ects, ensuring that progress will not be constrain...dated technology. , (PRWE...
(Date:11/26/2009)...olybdate (TM) has been shown in studies to be effe...e caused by an overload of copper, and certain met...however, is known about how the drug works at the ...rn University researchers now has provided an inva... bound to copper-loaded metallochaperones. The dru...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
..., Dec. 3, 2008 Joined by actress Maggie,Gyllenhaa...tionwide search for,five child Holiday Ambassadors...an event in New York City. The Duracell Holiday A...spread the joy of powering,up a gift for the first...
...., Dec. 3 Decision Resources, one of the,world,s ...armaceutical and,healthcare issues, finds that the...se in China is extremely low and will remain low t...eimer,s disease,population in China in 2012, less ...
... NextAdvisor.com has created a free g...ch to dieting. , San Fran....com , the trusted, independent source for compari...useful advice for those embarking on a new diet pl...
... Around 80 HBA, MBF and Mutual Commun...ir feet where their mouths were on Sunday to promo... charity in the inaugural HBA Great Australian Run... put their feet where their mouths were on Sunday ...
...Dec. 3 AGA Medical Corporation announced,today th...enne) approval for,its AMPLATZER(R) Cardiac Plug (...vasive solution for closing cardiac structures not...t addition to the interventional tools we have for...
...ec. 3, 2008 Scientists at UT Southwestern Medical...tein interferon plays a key role in "teaching" the...s of the same virus. , The findings, available on...therapies. , Typically, when a person is infecte...
Other Medicine News:Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 2Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 3Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 2Health News:Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012 3Health News:NextAdvisor.com Launches "Lose the Weight this Year: A Common Sense Dieter's Guide" 2Health News:HBA People Walk the Talk for Better Health in the HBA Great Australian Run 2Health News:AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug 2Health News:Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report 2
(Date:11/25/2009)... 25 Cempra Pharmaceuticals Inc. to...t and chief executive officer, will present at the...at 8:50 a.m. EST, December 1, 2009, at The New Yor...ll provide an overview of the company,s two leadin...f drug-resistant pathogens including MRSA. ,, ...
(Date:11/25/2009)...25 ChemoCentryx, Inc., announced...mpany,s PROTECT-1 (the Prospective Randomized Oral...raficet-EN(TM) (CCX282-B) in patients with moderat...efficacy with a favorable safety and tolerability ...cal efficacy in the reduction of disease severity ...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Vermillion, Inc. (VRML) (P... Plan of Reorganization and Disclosure Statement t...nkruptcy Court for the District of Delaware. A hea...ent is presently scheduled for December 8, 2009, w...heduled for January 7, 2010. ,, The Plan calls...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3